COMP <GO>
BW vs TMO // ALTMAN Z-SCORE & DEBT/EQUITY
Babcock & Wilcox Enterprises Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: BW 2
— TMO 9
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: TMO
LAST: $4.56 (0.00%) • MKT CAP: $679.3M
balance-sheet
0.20
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
balance-sheet
4.50
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BW VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BW | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 24.50% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 48.20% | 9.30% | +38.90 | BW | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.9x | 30.4x | -13.50 | BW | /valuation <GO> |
| Free Cash Flow Yield | -12.61% | 2.40% | -15.01 | TMO | /fcf-yield <GO> |
| Operating Margin | 3.50% | 17.40% | -13.90 | TMO | /operating-margins <GO> |
| Net Profit Margin | -5.60% | 15.10% | -20.70 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 1.10% | 3.90% | -2.80 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 0.20 | 4.50 | -4.30 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 8/9 | -6.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 30.6 | 62.9 | -32.33 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 36.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $679.3M | $262.22B | -$261.54B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BW REV | TMO REV | BW GROSS % | TMO GROSS % | BW FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $587.7M | $44.56B | 24.5% | — | -$85.7M | $6.29B |
| FY 2024 | $581.0M | $42.88B | 21.8% | — | -$129.9M | $7.27B |
| FY 2023 | $587.4M | $42.86B | — | — | -$42.3M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BW // BETA —
TMO // BETA 0.94